Charcot–Marie–Tooth (CMT) disease is characterized by hereditary sensorimotor polyneuropathy with foot deformity, sensorineural hearing loss, moderate developmental delay, and gait disturbance. CMT presenting with type 2 diabetes and an ulcer has not been reported. This article reports a man who presented with the symptoms mentioned above and also with a leg ulcer and type 2 diabetes. He was diagnosed with CMT disease based on family history and genetic testing. A skin defect in the left leg had manifested for more than 1 year, and results of initial fasting plasma glucose revealed type 2 diabetes. The evolution of these manifestations, coupled with a slowly progressive weakness, numbness, muscular wasting, and sensory impairment, strongly suggested the co-occurrence of 3 different diseases in the same individual.
FifeCECarterMJWalkerD. Why is it so hard to do the right thing in wound care?Wound Repair Regen. 2010;18:154-158.
2.
WinHHNDavenportCDelaneySKellyMSmithD. Charcot-Marie-Tooth disease complicating type 2 diabetes. J Am Podiatr Med Assoc. 2011;101:349-352.
3.
MurakamiTGarciaCAReiterLTLupski JamesR. Charcot-Marie-Tooth disease and related inherited neuropathies. Medicine (Baltimore). 1996;75:233-250.
4.
JudhanRJMaharajSRPerryADellonALMaharajD. Charcot-Marie-Tooth disease presenting as a nonhealing ulcer in a 26-year-old man. Microsurgery. 2012;32:223-226.
5.
RougeotCChabrierSCamdessancheJPPrieurFd’AnjouMCLatourP. Clinical, electrophysiological and genetic studies of two families with mutations in the GDAP1 gene. Neuropediatrics. 2008;39:184-187.
6.
BouchePGherardiRCathalaHLhermitteFCastaigneP. Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci. 1983;61:389-399.
7.
HardingAThomasP. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain. 1980;103:259-280.
8.
HensingerRMacEwenG. Spinal deformity associated with heritable neurological conditions: spinal muscular atrophy, Friedreich’s ataxia, familial dysautonomia, and Charcot-Marie-Tooth disease. J Bone Joint Surg Am. 1976;58:13-24.
9.
KumarSJMarksHGBowenJRMacEwenGD. Hip dysplasia associated with Charcot-Marie-Tooth disease in the older child and adolescent. J Pediatr Orthop. 1985;5:511-514.
10.
McGannRGurdA. The association between Charcot-Marie-Tooth disease and developmental dysplasia of the hip. Orthopedics. 2002;25:337-339.
11.
CucuzzellaTGuilleJMacEwenG. Charcot-Marie-Tooth disease associated with hip dysplasia: a case report. Del Med J. 1996;68:305-307.
12.
BenedettiSPrevitaliSCCovielloS. Analyzing histopathological features of rare Charcot-Marie-Tooth neuropathies to unravel their pathogenesis. Arch Neurol. 2010;67:1498-1505.
13.
LinPMaoFLiuQ. A novel deletion mutation in GJB1 causes X-linked Charcot-Marie-Tooth disease in a Han Chinese family. Muscle Nerve. 2010;42:922-926.
14.
MonesSBordignonBFontesM. Connexin 32 is involved in mitosis. Glia. 2012;60:457-464.
15.
DubourgOTardieuSBiroukN. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain. 2001;124(Pt 10):1958-1967.
16.
ApelqvistJ. Diagnostics and treatment of the diabetic foot. Endocrine. 2012;41:384-397.
17.
DinhTTecilazichFKafanasA. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012;61:2937-2947.
18.
ChowdhurySKSmithDRFernyhoughP. The role of aberrant mitochondrial bioenergetics in diabetic neuropathy [published online March 9, 2012]. Neurobiol Dis. doi:10.1016/ j.nbd.2012.03.016.
19.
AmiottEACohenMMSaint-GeorgesYWeissmanAMShawJM. A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover. Mol Biol Cell. 2009;20:5026-5035.
20.
ZuchnerSMersiyanovaIVMugliaM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36:449-451.
21.
KotruchowKKabzinskaDKarpinskaKKochanskiA. Molecular pathogenesis of hereditary motor and sensory neuropathy [in Polish]. Postepy Biochem. 2011;57:283-293.
22.
FeelySMLauraMSiskindCE. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology. 2011;76:1690-1696.
23.
DelcroixJDMichaelGJPriestleyJVTomlinsonDRFernyhoughP. Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes. 1998;47:1779-1785.
24.
SalehASmithDRBalakrishnanS. Tumor necrosis factor-alpha elevates neurite outgrowth through an NF-kappaB-dependent pathway in cultured adult sensory neurons: Diminished expression in diabetes may contribute to sensory neuropathy. Brain Res. 2011;1423:87-95.
25.
MizukamiHOgasawaraSYamagishiSTakahashiKYagihashiS. Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats. Eur J Clin Invest. 2011;41:442-450.
26.
LeeseGPMorrisAD. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: response to Boyko et al. Diabetes Care. 2006;29:2562-2563.
27.
MazzeoAStancanelliCRussoM. Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A. Muscle Nerve. 2012;45:451-452.
28.
LeeJEShunCTHsiehSCHsiehST. Skin denervation in vasculitic neuropathy. Arch Neurol. 2005;62:1570-1573.
29.
HsiehST. Pathology and functional diagnosis of small-fiber painful neuropathy. Acta Neurol Taiwan. 2010;19:82-89.
30.
Ceuterick-de GrooteCDe JonghePTimmermanV. Infantile demyelinating neuropathy associated with a de novo point mutation on Ser72 in PMP22 and basal lamina onion bulbs in skin biopsy. Pathol Res Pract. 2001;197:193-198.
